Our Company

1 of 1
1-2 of 2
Commercial payers spend more on hospital outpatient drugs at 340B participating hospitals13 March 2018 - By Michael T. Hunter and Jason Gomberg and Carol Kim - Article

This report replicates portions of the 2015 U.S. Government Accountability Office 340B report (a comparison of the per Medicare beneficiary hospital pharmacy outpatient drug spending at 340B hospitals and non-340B hospitals) on a commercially insured population to determine if the relationships found in the Medicare population existed in the commercial markets.

Insurance risk and its impact on provider shared risk payment models12 January 2018 - By Juliet M. Spector and Cory Gusland and Carol Kim - Article

A challenge facing providers and payers is to design shared risk payment models that incentivize providers to deliver efficient, high-quality care without assuming too much insurance risk from payers.

1 of 1

  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman